Mozaffarian D, Agarwal M, Aggarwal M, Alexander L, Apovian CM, Bindlish S, et al
So thats something we need to think more about
Sarris A, Cortes J, Kantarjian H, Pierce S, Smith T, Keating M, Koller C, Kornblau S, O'Brien S, Andreeff M
A later phase 3b trial of the higher 7.2 mg dose, STEP UP, reported mean bodyweight change of 18.7% at 72 weeks versus 15.6% at 2.4 mg and 3.9% with placebo
Currently, no company worldwide has completed the required oral toxicity studies, metabolism studies, and long-term safety evaluations for GHK-Cu and submitted a GRAS notification to the FDA
GLP-1 Lawsuits Phased Discovery Order Early in the Ozempic MDL, the drug makers urged the court to split the discovery process into two distinct phases, first addressing a number of what they refer to as cross cutting issues, which they suggest may lead to the dismissal of large numbers of lawsuits